Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LXEO

Lexeo Therapeutics Inc

Jun 18 • 04:00PM ET

4.93

-0.05 -1.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY BMRN VKTX KRYS KYMR NUVL RYTM AXSM MDGL NBIX

| Held by: VTI XBI IWM VXF IWN IBB KOMP VTWO DFAS DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.45	Insider Own	21.46%	Shs Outstand	74.09M	Perf Week	17.38%
Market Cap	387.11M	Forward P/E	-	EPS next Y	-1.28	Insider Trans	-0.43%	Shs Float	61.67M	Perf Month	10.04%
Enterprise Value	201.44M	PEG	-	EPS next Q	-0.29	Inst Own	100.16%	Short Float	22.34%	Perf Quarter	-14.85%
Income	-87.50M	P/S	-	EPS this Y	37.10%	Inst Trans	0.06%	Short Ratio	15.85	Perf Half Y	-49.33%
Sales	0.00M	P/B	1.58	EPS next Y	-9.04%	ROA	-46.54%	Short Interest	13.78M	Perf YTD	-50.35%
Book/sh	3.12	P/C	2.01	EPS next 5Y	26.06%	ROE	-54.75%	52W High	10.99 -55.14%	Perf Year	16.27%
Cash/sh	2.46	P/FCF	-	EPS past 3/5Y	5.73% -57.31%	ROIC	-37.05%	52W Low	3.60 36.94%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.46% 7.61%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	56.00%	Oper. Margin	-	ATR (14)	0.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	14.16	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.91	Recom	1.10
Dividend Gr. 3/5Y	- -	Current Ratio	14.16	EPS Q/Q	74.77%	SMA20	4.65%	Beta	1.36	Target Price	20.90
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	-9.27%	Rel Volume	1.70	Prev Close	4.98
Employees	59	LT Debt/Eq	0.02	Earnings	May 11 BMO	SMA200	-31.01%	Avg Volume	868.87K	Price	4.93
IPO	Nov 03, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	19.12% -	Trades		Volume	1,481,272	Change	-1.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)